Download presentation
Presentation is loading. Please wait.
Published byDana Greer Modified over 9 years ago
2
TB chemoprophylaxis Graham Bothamley Clinical Director, NE London TB Network
3
Questions 1.Do we know who will develop TB? 2.Who should take treatment? 3.How many will receive unnecessary treatment? 4.How many actually take treatment? 5.Is it cost-effective? 6.Is isoniazid the right treatment?
4
Latent TB infection or long-lasting TB immunity? Cochrane review: 1.68% over 5 years HIV+ PPD+ cohort: 4% over 22 months (7.9 cases per 100 person years) Human macrophages cannot kill Mtb 1-3 tubercle bacilli required for disease Selwyn et al. 1989. NEJM 320: 545
5
Children: tuberculin responses, risk of TB over first 9 years and timing of exposure Horsburgh. NEJM 2004; 350:2060 US data: 1962-1974
6
Adults: tuberculin responses, risk of TB over first 9 years and timing of exposure Horsburgh. NEJM 2004; 350:2060 US data: 1962-1974
7
Progression to TB Immigrant contacts of S+ve cases >16 yrs in Holland CriterionTB cases/ positives % (95% CI) Sensitivity (%) PPD 10 mm 9/2883.1 (1.3-5.0)100 PPD 15 mm 7/1843.8 (1.7-5.9)88 QFT-GIT5/1782.8 (1.0-4.6)63 T-SPOT.TB6/1813.3 (1.3-5.3)75 All IGRA patients had PPD>10 mm; 1/8 patients missed if 15 mm Kaplan Meier for progression, pos vs. neg: even PPD >15 mm P=0.081 812 contacts from 380 index cases Kik et al. Eur Respir J 2010; (in press)
8
Predictive values of IGRA Subjects (n) Tests (n) False results Mean % Range % NPV224232574098.882.1 - 100 PPV1034146717/4004.256 - 32 PPV-HIV+1031 5/568.931.2 - 32 TBNET review: Diel et al (ECDC)
9
PPD+: NNT to prevent 1 case TB ConditionNNTConditionNNT Transplant5Diabetes53.5 HIV+13.5Silicosis61 Gastrectomy23.5Unexplained WL66.5 Child contact24.5CRF on dialysis67 PPD conversion24.5Leukaemia91 IVDU30.5Immigrants93 Steroids98.5 No risk123.5 Rose. Arch Intern Med 2000; 160:1513
10
Treatment and harm Treat 72 to prevent one case of TB Treat 333 to cause isoniazid induced hepatitis (varies with age)
11
Hepatotoxicity of isoniazid Comstock & Edwards. Am Rev Respir Dis 1795; 111: 573
12
Adherence Horsburgh et al. Chest 2010; 137: 401-9 32 clinics 123/720 declined (17.1%: 14.5 - 20%) 1045/1994 (52.4%) failed to complete IJTLD 2008; 12: 1235 & 1352 3582 seen 8 had TB (0.2%) PPD+ = 996 227 refused and only 40% eligible (>35 yrs) 320 (8.9% total; 67% who started) completed
13
Isoniazid Active against rapidly dividing population Course longer than TB treatment Most hepatotoxic of TB drugs Cheap
14
Chemoprophylaxis? 3 year old Mother has smear-positive pulmonary tuberculosis BCG vaccinated PPD 5 mm response
15
Chemoprophylaxis? 16 year old Somali Mother had LN TB BCG vaccinated PPD 12 mm response
16
Chemoprophylaxis? 34 year old Russian Screened as a new entrant to EU Chest x-ray normal PPD 35 mm response
17
Chemoprophylaxis? 45 year old health care worker Occupational health screening To work with HIV+ Born in UK Visited relatives in India for 3m last year Chest x-ray normal PPD 16 mm response
18
Chemoprophylaxis? 37 year old from Guinea-Bissau HIV+ BCG vaccinated PPD 15 mm response
19
Chemoprophylaxis? 45 year old from Turkey Screened as new entrant BCG vaccinated Chest x-ray: one calcified granuloma PPD 12 mm response Quantiferon: 0.52 IU/ml (>0.35 IU/ml)
Similar presentations
© 2024 SlidePlayer.com Inc.
All rights reserved.